MX2019005256A - Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente. - Google Patents

Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.

Info

Publication number
MX2019005256A
MX2019005256A MX2019005256A MX2019005256A MX2019005256A MX 2019005256 A MX2019005256 A MX 2019005256A MX 2019005256 A MX2019005256 A MX 2019005256A MX 2019005256 A MX2019005256 A MX 2019005256A MX 2019005256 A MX2019005256 A MX 2019005256A
Authority
MX
Mexico
Prior art keywords
human
human animals
light chain
chain locus
lambda light
Prior art date
Application number
MX2019005256A
Other languages
English (en)
Inventor
J Murphy Andrew
Macdonald Lynn
Mcwhirter John
Voronina Vera
Harris Faith
Tu Naxin
Guo Chunguang
Levenkova Natasha
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2019005256A publication Critical patent/MX2019005256A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C12N2015/8518—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se proporcionan animales no humanos (y/o células no humanas) y métodos para usar y producir los mismos, cuyos animales no humanos (y/o células no humanas) tienen un genoma que comprende secuencias que codifican anticuerpos humanos (es decir, genes de inmunoglobulinas). Los animales no humanos descritos en la presente descripción expresan anticuerpos que contienen cadenas ligeras Ig? humanas, en su totalidad o en parte. En particular, los animales no humanos proporcionados en la presente descripción se caracterizan, en algunas modalidades, por la expresión de anticuerpos que contienen cadenas ligeras Ig? humanas, en su totalidad o en parte, que están codificadas por secuencias que codifican cadenas ligeras Ig? humanas insertadas en un locus endógeno de cadena ligera Ig? de dichos animales no humanos. Se proporcionan, además, métodos para producir anticuerpos a partir de animales no humanos.
MX2019005256A 2016-11-04 2017-11-03 Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente. MX2019005256A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662417845P 2016-11-04 2016-11-04
US201762567932P 2017-10-04 2017-10-04
PCT/US2017/060006 WO2018128691A1 (en) 2016-11-04 2017-11-03 Non-human animals having an engineered immunoglobulin lambda light chain locus

Publications (1)

Publication Number Publication Date
MX2019005256A true MX2019005256A (es) 2019-08-05

Family

ID=62025924

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019005256A MX2019005256A (es) 2016-11-04 2017-11-03 Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.
MX2021010556A MX2021010556A (es) 2016-11-04 2019-05-03 Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021010556A MX2021010556A (es) 2016-11-04 2019-05-03 Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.

Country Status (24)

Country Link
US (2) US10820582B2 (es)
EP (3) EP3766343B1 (es)
JP (4) JP6884860B2 (es)
KR (4) KR102319069B1 (es)
CN (2) CN109996441B (es)
AU (2) AU2017391167B2 (es)
BR (1) BR112019008675A2 (es)
CA (1) CA3038720A1 (es)
CY (1) CY1123491T1 (es)
DK (2) DK3766343T3 (es)
ES (2) ES2823305T3 (es)
HR (2) HRP20220888T1 (es)
HU (2) HUE052087T2 (es)
IL (2) IL308197A (es)
LT (2) LT3407709T (es)
MA (2) MA53935A (es)
MX (2) MX2019005256A (es)
PL (2) PL3407709T3 (es)
PT (2) PT3766343T (es)
RS (2) RS63390B1 (es)
RU (2) RU2021129958A (es)
SG (2) SG10201913483XA (es)
SI (2) SI3407709T1 (es)
WO (1) WO2018128691A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ719228A (en) * 2012-02-01 2022-08-26 Regeneron Pharma Humanized rodents that express heavy chains containg vl domains
US10813346B2 (en) 2015-12-03 2020-10-27 Trianni, Inc. Enhanced immunoglobulin diversity
DK3766343T3 (da) 2016-11-04 2022-06-20 Regeneron Pharma Ikke-humane dyr med et manipuleret immunoglobulin-lambda-letkædelocus
KR20200135397A (ko) 2018-03-24 2020-12-02 리제너론 파마슈티칼스 인코포레이티드 펩티드-mhc 복합체에 대한 치료 항체를 생성하기 위한 유전적으로 변형된 비인간 동물, 이의 제조 방법
CN116420679A (zh) 2018-03-26 2023-07-14 瑞泽恩制药公司 用于测试治疗剂的人源化啮齿动物
CA3103646C (en) 2018-06-14 2023-06-27 Regeneron Pharmaceuticals, Inc. Non-human animals capable of engineered dh-dh rearrangement and uses thereof
BR112021016173A2 (pt) 2019-02-22 2021-11-03 Regeneron Pharma Roedor geneticamente modificado, métodos de produção de um roedor geneticamente modificado e de produção de um anticorpo anti-nav1.7, célula ou tecido isolado de roedor, linhagem celular imortalizada, embrião de roedor, construto de ácido nucleico de direcionamento, e, hibridoma
KR20220025839A (ko) * 2019-07-01 2022-03-03 트리아니, 인코포레이티드 유전자이식 포유동물 및 이의 사용 방법
EP4211155A1 (en) 2020-09-11 2023-07-19 Regeneron Pharmaceuticals, Inc. Identification and production of antigen-specific antibodies
CN116848254A (zh) 2020-12-16 2023-10-03 瑞泽恩制药公司 表达人源化Fcα受体的小鼠
KR20230124594A (ko) 2020-12-23 2023-08-25 리제너론 파마슈티칼스 인코포레이티드 막관통 단백질 및 이를 생산하는 세포에 결합하는 항체를 수득하는 방법
WO2022140219A1 (en) 2020-12-23 2022-06-30 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding anchor modified antibodies and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0746609A4 (en) * 1991-12-17 1997-12-17 Genpharm Int NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
GB9823930D0 (en) 1998-11-03 1998-12-30 Babraham Inst Murine expression of human ig\ locus
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
ES2645563T3 (es) 2001-11-30 2017-12-05 Amgen Fremont Inc. Animales transgénicos que portan genes de cadena ligera de Ig humana
CN1852925A (zh) * 2003-07-15 2006-10-25 人类多克隆治疗公司 人源化免疫球蛋白基因座
CA2652976C (en) 2006-06-02 2015-08-11 Regeneron Pharmaceuticals, Inc. High affinity antibodies to human il-6 receptor
KR102362774B1 (ko) 2008-09-30 2022-02-15 아블렉시스, 엘엘씨 키메라 항체의 제조를 위한 인간 이외의 포유동물
DK2379727T3 (en) * 2008-12-18 2017-01-16 Univ Erasmus Med Ct Rotterdam NON-HUMAN TRANSGENE ANIMALS EXPRESSING HUMANIZED ANTIBODIES AND USE THEREOF
US20120204278A1 (en) * 2009-07-08 2012-08-09 Kymab Limited Animal models and therapeutic molecules
WO2011004192A1 (en) * 2009-07-08 2011-01-13 Genome Research Limited Animal models and therapeutic molecules
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
PT3034608T (pt) 2010-06-22 2019-05-28 Regeneron Pharma Ratinhos expressando uma cadeia leve híbrida de imunoglobulina com uma região variável humana
NZ776770A (en) * 2011-02-25 2023-03-31 Regeneron Pharma Adam6 mice
SI2627773T1 (sl) 2011-10-17 2017-12-29 Regeneron Pharmaceuticals, Inc., Omejena težka veriga imunoglobulinov pri miših
US9253965B2 (en) * 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
PL2793567T3 (pl) 2011-12-20 2019-09-30 Regeneron Pharmaceuticals, Inc. Myszy z humanizowanym łańcuchem lekkim
BR112015019950B1 (pt) 2013-02-20 2023-02-14 Regeneron Pharmaceuticals, Inc Método para gerar linhagem de células-tronco embrionárias (es) de rato, e, cultura in vitro
SI2840892T1 (en) * 2013-02-20 2018-08-31 Regeneron Pharmaceuticals, Inc. Animals other than humans with modified immunoglobulin heavy chain sequences
US9788534B2 (en) 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
CN105683365A (zh) * 2013-10-01 2016-06-15 科马布有限公司 动物模型及治疗分子
AU2014360811B2 (en) 2013-12-11 2017-05-18 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a genome
HUE049776T2 (hu) 2014-06-06 2020-10-28 Regeneron Pharma Módszerek és készítmények egy célzott lókusz módosítására
PT3354732T (pt) 2014-06-23 2020-04-02 Regeneron Pharma Montagem de dna mediada por nuclease
SI3221457T1 (sl) 2014-11-21 2019-08-30 Regeneron Pharmaceuticals, Inc. Postopki in sestavki za ciljno genetsko modifikacijo z uporabo vodilnih RNK v parih
AU2015364427B2 (en) 2014-12-19 2021-05-27 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modification through single-step multiple targeting
DK3766343T3 (da) 2016-11-04 2022-06-20 Regeneron Pharma Ikke-humane dyr med et manipuleret immunoglobulin-lambda-letkædelocus

Also Published As

Publication number Publication date
HRP20201403T1 (hr) 2020-11-27
EP3407709B1 (en) 2020-07-29
SI3766343T1 (sl) 2022-06-30
JP6884860B2 (ja) 2021-06-09
CY1123491T1 (el) 2022-03-24
IL308197A (en) 2024-01-01
KR102492433B1 (ko) 2023-01-30
RU2757665C2 (ru) 2021-10-20
RU2021129958A (ru) 2021-11-02
CN109996441A (zh) 2019-07-09
HUE061980T2 (hu) 2023-09-28
RS60886B1 (sr) 2020-11-30
HRP20220888T1 (hr) 2022-10-28
PT3766343T (pt) 2022-05-30
IL266282B2 (en) 2024-04-01
AU2017391167A1 (en) 2019-05-30
ES2823305T3 (es) 2021-05-06
JP2023053400A (ja) 2023-04-12
DK3766343T3 (da) 2022-06-20
LT3766343T (lt) 2022-06-10
RS63390B1 (sr) 2022-08-31
AU2024200582A1 (en) 2024-03-28
MX2021010556A (es) 2021-10-01
CN109996441B (zh) 2022-02-08
LT3407709T (lt) 2020-10-12
WO2018128691A1 (en) 2018-07-12
KR20230020550A (ko) 2023-02-10
HUE052087T2 (hu) 2021-04-28
KR20210134059A (ko) 2021-11-08
US20210029978A1 (en) 2021-02-04
MA53935A (fr) 2021-12-22
JP2022130725A (ja) 2022-09-06
PT3407709T (pt) 2020-08-20
JP2020501516A (ja) 2020-01-23
JP2021090455A (ja) 2021-06-17
SI3407709T1 (sl) 2020-10-30
KR102319069B1 (ko) 2021-11-01
RU2019112589A3 (es) 2021-03-30
MA44091A (fr) 2018-10-24
EP3407709A1 (en) 2018-12-05
EP3766343A1 (en) 2021-01-20
PL3407709T3 (pl) 2021-01-11
CN114369157A (zh) 2022-04-19
PL3766343T3 (pl) 2022-09-26
JP7386292B2 (ja) 2023-11-24
KR20240055863A (ko) 2024-04-29
CA3038720A1 (en) 2018-07-12
SG10201913483XA (en) 2020-03-30
US10820582B2 (en) 2020-11-03
SG11201903344XA (en) 2019-05-30
AU2017391167B2 (en) 2024-02-15
ES2915609T3 (es) 2022-06-23
KR20190076024A (ko) 2019-07-01
KR102658529B1 (ko) 2024-04-19
RU2019112589A (ru) 2020-12-04
EP3766343B1 (en) 2022-05-11
IL266282A (en) 2019-06-30
EP3407709B9 (en) 2021-10-06
EP4082334A1 (en) 2022-11-02
US20180125043A1 (en) 2018-05-10
WO2018128691A8 (en) 2019-02-28
BR112019008675A2 (pt) 2019-07-09
DK3407709T3 (da) 2020-08-31
NZ753456A (en) 2021-08-27
IL266282B1 (en) 2023-12-01

Similar Documents

Publication Publication Date Title
MX2021010556A (es) Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.
MX2020005830A (es) Animales no humanos que tienen una cadena ligera lambda de inmunoglobulina modificada y usos de estos.
CY1122036T1 (el) Μη ανθρωπινα ζωα που εκφραζουν αντισωματα τα οποια εχουν μια κοινη ελαφρια αλυσιδα
AR102888A1 (es) Animales no humanos que tienen un gen humanizado de agrupamiento de diferenciación 47
MY172718A (en) Humanized universal light chain mice
PH12016500342A1 (en) Non-human animals having a humanized signal-regulatory protein gene
CY1121798T1 (el) Αντισωματα ελαφριων αλυσιδων τροποποιημενων με ιστιδινη και γενετικα τροποποιημενα ζωα πλην του ανθρωπου για τη δημιουργια αυτων
NZ629639A (en) Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
MY185881A (en) Non-human animals with modified immunoglobulin heavy chain sequences
CY1123046T1 (el) Ζωα εκτος του ανθρωπου που εχουν ανθρωποποιημενους υποδοχεις fc-γ
IN2014DN08163A (es)
NZ734504A (en) Humanized rodents that express heavy chains containing vl domains
MX358206B (es) Animales no humanos que tienen un gen humanizado de un ligando inductor de la proliferacion.
MY183188A (en) Non-human animals having a humanized b-cell activating factor gene
MX2021014818A (es) Anticuerpos monoclonales anti-cd303.
MX2015012540A (es) Ratón de cadena ligera común.
PH12020551292A1 (en) Moscato wine replicas produced from individual components
MX2018008701A (es) Roedores que tienen una region de diversidad de cadena pesada modificada geneticamente.
ZA202001389B (en) Non-human animals expressing humanized c1q complex